An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 03 Jan 2013
At a glance
- Drugs AT 101 (Primary) ; Antineoplastics
- Indications Oesophageal cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 03 Jan 2013 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 05 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Feb 2010 Planned end date changed from Aug 2009 to Aug 2010 as reported by ClinicalTrials.gov.